Phase II Randomized Trial Comparing Sequential First-Line Everolimus and Second-Line Sunitinib Versus First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic Renal Cell Carcinoma

✍ Scribed by Motzer, R. J.; Barrios, C. H.; Kim, T. M.; Falcon, S.; Cosgriff, T.; Harker, W. G.; Srimuninnimit, V.; Pittman, K.; Sabbatini, R.; Rha, S. Y.; Flaig, T. W.; Page, R.; Bavbek, S.; Beck, J. T.; Patel, P.; Cheung, F.-y.; Yadav, S.; Schiff, E. M.; Wang, X.; Niolat, J.; Sellami, D.; Anak, O.; Knox, J. J.

• Book ID: 126192192
• Publisher: American Society of Clinical Oncology
• Year: 2014
• Tongue: English
• Weight: 282 KB
• Volume: 32
• Category: Article
• ISSN: 0732-183X
• DOI: 10.1200/JCO.2013.54.6911